Skip to main content
Premium Trial:

Request an Annual Quote

UPDATE: Prolias Sues PDI for Breach of Contract; PDI Denies Liability

This article has been updated with a comment from PDI.

NEW YORK (GenomeWeb) – Prolias Technologies today said it has filed a lawsuit against PDI alleging breach of contract, breach of covenant of good faith and fair dealing, intentional interference with contract, and breach of fiduciary duty.  

Prolias, a New York-based molecular diagnostics firm, filed its lawsuit in Superior Court of New Jersey for the County of Morris. 

Prolias accused PDI of breaching a joint venture agreement reached by the firms to validate, commercialize, and monetize Prolias' Thymira, a microRNA-based thyroid cancer test. Prolias said that PDI breached its obligations under the agreement, and among other things, it failed to effectively and timely validate Thymira; acquired a competitor and developed its own test in lieu of Thymira; and interfered with a license agreement between Prolias and Cornell University

Additionally, Prolias said that upon information and belief, PDI attempted to purchase the license agreement from Cornell directly and to the exclusion of Prolias. 

Prolias further said that PDI "practically usurped" the Thymira name from Prolias and named its competing product Thyramir. 

In a statement sent to GenomeWeb, PDI said,"We deny liability, intend to defend vigorously, and will present our case in the courts not the press."

The Scan

Cancer Survival Linked to Mutational Burden in Pan-Cancer Analysis

A pan-cancer paper appearing in JCO Precision Oncology suggests tumor mutation patterns provide clues for predicting cancer survival that are independent of other prognostic factors.

Australian Survey Points to Public Support for Genetic Risk Disclosure in Relatives of At-Risk Individuals

A survey in the European Journal of Human Genetics suggests most adult Australians are in favor of finding out if a relative tests positive for a medically actionable genetic variant.

Study Links Evolution of Stony Coral Skeleton to Bicarbonate Transporter Gene

A PNAS paper focuses on a skeleton-related bicarbonate transporter gene introduced to stony coral ancestors by tandem duplication.

Hormone-Based Gene Therapy to Sterilize Domestic Cat

A new paper in Nature Communication suggests that gene therapy could be a safer alternative to spaying domestic cats.